期刊文献+

顺铂对蛋白酶体抑制作用的研究

Inhibitory effect of cisplatin on proteasome
下载PDF
导出
摘要 目的 研究顺铂对蛋白酶体的抑制作用。方法 采用蛋白酶体特异性底物S LLVY AMC、B LRR AMC及Z LLE AMC观察了顺铂对纯化的人 2 0S蛋白酶体及CCD 110 3KidTr细胞内蛋白酶体活力的影响 ,同时分析了受蛋白酶体降解的p5 3蛋白在蛋白质及mRNA水平的表达。结果 顺铂对纯化的人 2 0S蛋白酶体具有明显的抑制作用 ,对 3种酶活力抑制作用的半数抑制浓度 (IC50 )分别为 3 2 17(S LLVY AMC)、3 7 96(B LRR AMC)和 3 7 81μg ml(Z LLE AMC)。在 3 0和 60μg ml顺铂作用下 ,CCD 110 3KidTr细胞内蛋白酶体活力也受到显著抑制。在 3 0 μg ml顺铂作用下 ,p5 3mRNA表达在 3、6、12和 2 4h未见明显改变 ,而p5 3蛋白质水平在 3、6h明显增高。结论 顺铂对蛋白酶体活力有抑制作用 ,但对蛋白酶体3种酶活力的抑制没有特异性。顺铂作用CCD 110 3KidTr细胞后p5 3蛋白质表达增高 ,可能与蛋白酶体抑制有关。 Objective To study the inhibitiory effect of cislatin on proteasome.Methods Specific substrates of proteasome,S-LLVY-AMC,B-LRR-AMC,Z-LEEAMC were used to determine the activities of both purified human 20S proteasome and CCD-1103KidTr cellular proteasome treated by cisplatin.p53,one of the proteasome substrates,was analyzed at protein and mRNA levels.Results Cisplatin had a significant inhibitory effect on purified human 20S proteasome.IC_ 50 values of three enzyme activities were 32\^17 μg/ml(S-LLVY-AMC),37\^96 μg/ml(B-LRR-AMC),37\^81 μg/ml(Z-LEE-AMC),respectively.Similar effects were observed in CCD-1103KidTr cells treated by 30 and 60 μg/ml cisplatin.Under 30 μg/ml cisplatin,no obvious changes of p53 mRNA levels were observed at 3,6,12,24 while p53 protein level increased at 3 and 6 h. Conclusion Cisplatin has some but not specific inhibitory effect on proteasome.The increased p53 protein levels of CCD-1103KidTr cells treated with cisplatin may be related to inhibition of proteasome.
出处 《卫生毒理学杂志》 CSCD 北大核心 2003年第2期84-86,共3页 Journal of Health Toxicology
关键词 顺铂 蛋白酶体 抑制作用 P53蛋白 Cisplatin Proteasome p53
  • 相关文献

参考文献10

  • 1Coux O, Tanaka K, Goldberg A L. Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem, 1996,65:801-847.
  • 2Stein R, Melandri F, Dick L. Kinetic characterization of the chymotryptuc activity of the 20S proteasome. Biochemistry,1996,35 : 3899-3908.
  • 3Anderson ME, Naganumma A, Meister A. Protection against cisplatin toxicity by administration of glutathione ester. FASEB,1990,4:3251-3255.
  • 4Cullinane C, Mazur SJ, Essigmann JM, et al. Inhibition of RNA polymerase II transcription in human cell extracts by cisplatin DNA damage. Biochemistry, 1999,38:6204-6212.
  • 5Duman RK, Heath RT, Bose RN. Inhibition of Escherichia coli DNA polymerase- I by the anti-cancer drug cis-diaminedichlo-roplatinum( II ) : what roles do polymerases play in cis-plaitin induced cytotoxicity? FEBS Letters. 1999,455 : 49-54.
  • 6Gardner RC, Assinder SJ, Christle G, et al. Characterization of peptidyl boronic acid inhibitors of mammalian 20S and 26S proteasomes and their inhibition of proteasomes in cultured cells.Biochem J,2000,346 : 447-454.
  • 7Adams J, Palomebella VJ, Sausville EA, et al. Proteasome inhibitors: A novel class of potent and effective anti-tumor agents.Cancer Res, 1999,59 : 2615-2622.
  • 8Maki CG, Huibregtse JM, Howley PM. In vivo ubiquitination and proteasome-meiated degradation of p53. Cancer Res, 1996,56 : 2649-2654.
  • 9Chang YC,Lee YS,Tejima T,et al. Mdm2 and bax,downstream mediators of the p53 response, are degraded by the ubiquitinproteasome pathway. Cell Growth Differ, 1998,9: 79-84.
  • 10Isoe T, Naito M, Shirai A, et al. Inhibition of different steps of the ubiquitin system by cisplatin and aclarubicin. Biochim Biophys Acta, 1992,1117 : 131-135.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部